Validation, Commissioning & Design Featured Articles
-
Nasal Inhalation Delivery – An Introduction Guide
10/21/2024
Unlock the potential of nasal inhalation for delivering active pharmaceutical ingredients by exploring the benefits of both liquid and dry powder formulations as companies drive innovation in the field.
-
Harnessing Digitalization In Legacy Pharmaceutical Manufacturing
10/21/2024
Digital technologies are revolutionizing cleaning validation in decades-old pharmaceutical facilities. Learn about innovative non-intrusive methods to overcome the digital divide in legacy equipment.
-
A Data-Driven Approach to Cleaning Validation
10/21/2024
Discover how Ongoing Process Verification, guided by PAT and digital integration, ensures consistent cleaning efficacy, reduces risks, and optimizes production efficiency in the pharmaceutical industry.
-
Driving Continuous Improvement: Pushing Through The Barriers To Change
10/15/2024
Discover how continuous improvement drives efficiency in pharmaceutical manufacturing. Learn strategies to harmonize processes and reduce environmental impact in this thoughtful exploration.
-
Are These 5 Misconceptions Keeping You From Modernizing QC?
10/15/2024
Explore common misconceptions that obstruct progress and why overcoming these barriers early provides a competitive edge when preparing for commercialization.
-
Computer Systems Validation Pitfalls, Part 1: Methodology Violations
10/9/2024
When computer systems validation work is not performed according to protocol instructions — by cutting corners on quality outputs with the focus on profit as the main driver — this can result in drug and device companies losing profits and efficiencies.
-
Enhanced Risk? EMA Issues New Guidance For OSD Co-processed Excipients
10/9/2024
In recent years, there has been a drive toward the use of co-processed excipients to aid leaner manufacturing. This has prompted the European Medicines Agency (EMA) to develop a new guidance document, Questions and Answers regarding co-processed excipients used in solid oral dosage forms (H & V). The public consultation period is open until the end of 2024.
-
How Document Control Software Supports Digital Transformation Efforts
10/9/2024
Embrace digital transformation in pharma manufacturing with advanced document control and quality management systems to enhance compliance, streamline processes, and accelerate time to market.
-
Is Your Pharma QMS Equipped To Handle Risk?
10/9/2024
In a rapidly evolving industry, see why adopting digital solutions is essential for achieving operational excellence and staying competitive.
-
FDA Product Recalls: A Wake-Up Call For Life Sciences Manufacturers
10/9/2024
Discover why manufacturers must adopt more consumer-centric recall strategies to maintain trust and safeguard their market position.